1.
Indian J Lepr
;
2006 Apr-Jun; 78(2): 105-11
Article
in English
| IMSEAR
| ID: sea-54890
2.
Indian J Lepr
;
2004 Apr-Jun; 76(2): 171-2
Article
in English
| IMSEAR
| ID: sea-55075
3.
Indian J Lepr
;
2004 Apr-Jun; 76(2): 105-6
Article
in English
| IMSEAR
| ID: sea-54297
4.
Indian J Public Health
;
2003 Oct-Dec; 47(4): 183-7
Article
in English
| IMSEAR
| ID: sea-109536
5.
Indian J Lepr
;
2001 Oct-Dec; 73(4): 420-3
Article
in English
| IMSEAR
| ID: sea-54664
6.
Indian J Lepr
;
2000 Jan-Mar; 72(1): 65-8
Article
in English
| IMSEAR
| ID: sea-55564
7.
Hansen. int
;
(n.esp): 7-13, 1998. tab
Article
in English
| LILACS, SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP
| ID: biblio-1226372
8.
Hansen. int
;
(n.esp): 7-13, 1998. tab
Article
in English
| LILACS
| ID: lil-462779
9.
Indian J Lepr
;
1994 Jan-Mar; 66(1): 1-10
Article
in English
| IMSEAR
| ID: sea-55248
10.
Indian J Lepr
;
1992 Oct-Dec; 64(4): 521-7
Article
in English
| IMSEAR
| ID: sea-55316
ABSTRACT
Planning for disease control requires estimates of the number of leprosy patients from local to global levels. From the mid-sixties to the mid-eighties, global estimates appeared to be constant at between 10 and 12 million. The introduction of multidrug therapy (MDT) in many countries and the consequent reduction of prevalence of the disease has necessitated a reassessment of the global estimate. Based on available information and its interpretation, the number of leprosy cases in the world in 1991 has been estimated at 5.5 million. The number of individuals with deformities due to leprosy, including persons now cured of the disease, has been estimated at between two and three million.
Subject(s)
Humans , Leprosy/epidemiology , Global Health
11.
Indian J Lepr
;
1991 Jul-Dec; 63(3-4): 401-9
Article
in English
| IMSEAR
| ID: sea-54426
Subject(s)
Drug Therapy, Combination , Humans , Leprostatic Agents , Leprosy/epidemiology , Population Surveillance , Prevalence , Global Health
12.
Indian J Lepr
;
1990 Oct-Dec; 62(4): 448-58
Article
in English
| IMSEAR
| ID: sea-54853
Subject(s)
Clofazimine/administration & dosage , Dapsone/administration & dosage , Developing Countries , Drug Resistance, Microbial , Drug Therapy, Combination , Ethionamide/administration & dosage , Humans , India/epidemiology , Leprostatic Agents/administration & dosage , Leprosy/drug therapy , Mycobacterium leprae/drug effects , Prothionamide/administration & dosage , Rifampin/administration & dosage , Thioamides/administration & dosage , World Health Organization
13.
Indian J Lepr
;
1989 Jul; 61(3): 323-7
Article
in English
| IMSEAR
| ID: sea-55479
Subject(s)
Animals , Clofazimine/administration & dosage , Dapsone/administration & dosage , Drug Administration Schedule , Drug Therapy, Combination , Humans , Isonicotinic Acids/administration & dosage , Leprosy/drug therapy , Mice , Prothionamide/administration & dosage , Rifampin/administration & dosage
14.
Southeast Asian J Trop Med Public Health
;
1988 Sep; 19(3): 525-34
Article
in English
| IMSEAR
| ID: sea-33389
15.
Indian J Lepr
;
1988 Apr; 60(2): 149-58
Article
in English
| IMSEAR
| ID: sea-54499
16.
In. Dharmendra, M. Leprosy. Bombay, Samant and Company, 1985. p.1095-1108.
Monography
in English
|
LILACS-Express
| LILACS, SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP
| ID: biblio-1244085
17.
Manaus; s.n; 1984. 5 p. tab.
Non-conventional
in Portuguese
|
LILACS-Express
| LILACS, SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP
| ID: biblio-1235201
18.
Washington, D.C; Organización Panamericana de la Salud; 1984. 40 p. tab. (PNSP/84-01).
Monography
in Spanish
| LILACS
| ID: lil-374257
19.
Article
in English
| IMSEAR
| ID: sea-16287
Subject(s)
Acedapsone/therapeutic use , Adolescent , Age Factors , Child , Child, Preschool , Dapsone/analogs & derivatives , Female , Humans , Infant , Leprosy/genetics , Male , Sex Factors
20.
Article
in English
| IMSEAR
| ID: sea-20734